NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 874 filers reported holding NOVARTIS A G in Q3 2016. The put-call ratio across all filers is 1.04 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $584,000 | -41.9% | 7,396 | -39.3% | 0.39% | -39.2% |
| Q2 2016 | $1,005,000 | -34.3% | 12,182 | -42.3% | 0.64% | -35.8% |
| Q1 2016 | $1,530,000 | -50.5% | 21,119 | -41.2% | 0.99% | -29.7% |
| Q4 2015 | $3,092,000 | -6.4% | 35,942 | -0.0% | 1.41% | -11.3% |
| Q3 2015 | $3,305,000 | -6.3% | 35,956 | +0.3% | 1.59% | +5.8% |
| Q2 2015 | $3,527,000 | -4.8% | 35,866 | -4.6% | 1.50% | -9.1% |
| Q1 2015 | $3,706,000 | -99.9% | 37,583 | -3.6% | 1.66% | -2.3% |
| Q4 2014 | $3,611,146,000 | +99462.9% | 38,972 | +1.1% | 1.69% | +4.4% |
| Q3 2014 | $3,627,000 | +5.4% | 38,530 | +1.4% | 1.62% | +6.4% |
| Q2 2014 | $3,441,000 | +1.0% | 38,007 | -9.0% | 1.53% | -3.0% |
| Q1 2014 | $3,406,000 | +0.5% | 41,749 | -0.9% | 1.57% | +0.9% |
| Q4 2013 | $3,388,000 | +4.8% | 42,147 | -0.0% | 1.56% | -3.6% |
| Q3 2013 | $3,234,000 | +10.9% | 42,164 | +2.2% | 1.62% | +0.6% |
| Q2 2013 | $2,916,000 | – | 41,239 | – | 1.61% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Newman Dignan & Sheerar, Inc. | 3,739 | $353,074,000 | 56.77% |
| Susquehanna International Securities, Ltd. | 118,837 | $11,222,000 | 8.15% |
| MANAGED ASSET PORTFOLIOS, LLC | 336,762 | $31,800,000 | 5.59% |
| Martin Investment Management, LLC | 169,019 | $15,960,000 | 5.10% |
| SCHARF INVESTMENTS, LLC | 1,197,539 | $113,083,000 | 4.26% |
| GARLAND CAPITAL MANAGEMENT INC | 50,705 | $4,788,000 | 4.06% |
| Mawer Investment Management Ltd. | 6,625,594 | $625,655,000 | 3.69% |
| SPHERA FUNDS MANAGEMENT LTD. | 429,000 | $40,510,000 | 3.60% |
| First Fiduciary Investment Counsel, Inc. | 196,693 | $18,574,000 | 3.48% |
| PROFESSIONAL ADVISORY SERVICES INC | 227,971 | $21,527,000 | 3.46% |